The nebulizer market is witnessing growth and is projected to reach USD 1,698.1 million by 2030. This development can be credited to the increasing elderly populace, rising consumption of cigarettes, rising cases of respiratory illnesses, and rising occurrence of COVID-19.

On the basis of product type, the pneumatic nebulizer category generated the highest revenue, mainly because pneumatic nebulizers are tough and provide a variety of particle sizes, with no medicine limitations. As a result, such alternatives are common among patients, mainly the elderly.

During the projection period, the portable nebulizer category will witness quicker development within the portability segment. This will be because of the growing elderly populace and its rising demand for suitable treatment. The World Population Ageing 2019 statement by the United Nations (UN) projects that the populace of individuals old 65 years or more will increase from 703 million in 2019 to 1.5 billion by 2050.

Request for sample copy of this report: https://www.psmarketresearch.com/market-analysis/nebulizer-market-report/report-sample

In recent years, on the basis of application segment, the asthma category, had the largest share in the nebulizer industry, mainly because of the rising number of asthma cases. As per the World Health Organization, over 339 million individuals are currently suffering from asthma, and it is the most common chronic illness among kids.

On the basis of end-user, the hospitals and ASCs category, led the industry for nebulizers, and the trend is projected to remain during the projection period. This can be credited to the higher footfall of patients at such healthcare units and the easy availability of hospitals to individuals of all income levels.

In recent years, the North American region contributed the highest revenue from the sale of nebulizers, because of the high occurrence of respiratory illnesses, product introductions, and enormous healthcare investments in the continent.

During the projection period, the APAC region is projected to witness the fastest development in the nebulizer industry, because of the rising demand for generic nebulized medications, rising count of tobacco smokers, growing healthcare expenditure, and increasing air pollution levels. 

Nations like Japan, China, and India have a huge count of cigarette smokers, which has led to a significant growth in the cases of respiratory illnesses. Because of these factors, the need for nebulizers will be boosted in the coming years.

The WHO states that over 3 million individuals die of chronic disruptive pulmonary illness per annum, thus accounting for close to 6% of the worldwide deaths. The association also mentions that 90% of COPD demises happen in low- and middle-income nations. 

Nebulizers are needed to treat such patients; hence, a huge count of respiratory syndrome cases is propelling the nebulizer industry, by leading to the increasing gaining of such medical devices by healthcare centers and people.